QQQ   350.00 (-1.36%)
AAPL   178.00 (-0.68%)
MSFT   323.72 (-2.98%)
META   265.11 (-2.22%)
GOOGL   122.72 (-3.61%)
AMZN   121.50 (-4.04%)
TSLA   224.61 (+1.49%)
NVDA   377.61 (-2.31%)
NIO   7.82 (-0.76%)
BABA   85.54 (-1.34%)
AMD   118.32 (-4.76%)
T   15.98 (+1.98%)
F   13.49 (+4.33%)
MU   67.19 (-0.52%)
CGC   0.72 (-1.97%)
GE   106.07 (+0.58%)
DIS   92.47 (+0.34%)
AMC   4.71 (+1.51%)
PFE   38.83 (+1.20%)
PYPL   64.08 (-1.45%)
NFLX   400.67 (+0.35%)
QQQ   350.00 (-1.36%)
AAPL   178.00 (-0.68%)
MSFT   323.72 (-2.98%)
META   265.11 (-2.22%)
GOOGL   122.72 (-3.61%)
AMZN   121.50 (-4.04%)
TSLA   224.61 (+1.49%)
NVDA   377.61 (-2.31%)
NIO   7.82 (-0.76%)
BABA   85.54 (-1.34%)
AMD   118.32 (-4.76%)
T   15.98 (+1.98%)
F   13.49 (+4.33%)
MU   67.19 (-0.52%)
CGC   0.72 (-1.97%)
GE   106.07 (+0.58%)
DIS   92.47 (+0.34%)
AMC   4.71 (+1.51%)
PFE   38.83 (+1.20%)
PYPL   64.08 (-1.45%)
NFLX   400.67 (+0.35%)
QQQ   350.00 (-1.36%)
AAPL   178.00 (-0.68%)
MSFT   323.72 (-2.98%)
META   265.11 (-2.22%)
GOOGL   122.72 (-3.61%)
AMZN   121.50 (-4.04%)
TSLA   224.61 (+1.49%)
NVDA   377.61 (-2.31%)
NIO   7.82 (-0.76%)
BABA   85.54 (-1.34%)
AMD   118.32 (-4.76%)
T   15.98 (+1.98%)
F   13.49 (+4.33%)
MU   67.19 (-0.52%)
CGC   0.72 (-1.97%)
GE   106.07 (+0.58%)
DIS   92.47 (+0.34%)
AMC   4.71 (+1.51%)
PFE   38.83 (+1.20%)
PYPL   64.08 (-1.45%)
NFLX   400.67 (+0.35%)
QQQ   350.00 (-1.36%)
AAPL   178.00 (-0.68%)
MSFT   323.72 (-2.98%)
META   265.11 (-2.22%)
GOOGL   122.72 (-3.61%)
AMZN   121.50 (-4.04%)
TSLA   224.61 (+1.49%)
NVDA   377.61 (-2.31%)
NIO   7.82 (-0.76%)
BABA   85.54 (-1.34%)
AMD   118.32 (-4.76%)
T   15.98 (+1.98%)
F   13.49 (+4.33%)
MU   67.19 (-0.52%)
CGC   0.72 (-1.97%)
GE   106.07 (+0.58%)
DIS   92.47 (+0.34%)
AMC   4.71 (+1.51%)
PFE   38.83 (+1.20%)
PYPL   64.08 (-1.45%)
NFLX   400.67 (+0.35%)
NASDAQ:OTIC

Otonomy (OTIC) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.0085
▼
$0.0085
50-Day Range
$0.01
▼
$0.12
52-Week Range
$0.01
▼
$2.54
Volume
N/A
Average Volume
937,525 shs
Market Capitalization
$582,479.50
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$0.50
ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media
Get Otonomy News Delivered to You Automatically

Sign up to receive the latest news and ratings for OTIC and its competitors with MarketBeat's FREE daily newsletter.



OTIC Media Mentions By Week

OTIC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OTIC
News Sentiment
▼
-0.24

0.51
▲
Average
Medical
News Sentiment

OTIC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OTIC Articles
This Week
▼
0

1
▲
OTIC Articles
Average Week

SourceHeadline
MarketBeat logoOtonomy (NASDAQ:OTIC) Receives New Coverage from Analysts at StockNews.com
americanbankingnews.com - May 10 at 4:44 AM
MarketBeat logoOtonomy (NASDAQ:OTIC) vs. Mainz Biomed (NASDAQ:MYNZ) Head to Head Analysis
americanbankingnews.com - April 29 at 4:56 AM
MarketBeat logoOtonomy (NASDAQ:OTIC) Now Covered by Analysts at StockNews.com
americanbankingnews.com - April 24 at 5:24 AM
MarketBeat logoOtonomy (NASDAQ:OTIC) Now Covered by StockNews.com
americanbankingnews.com - April 17 at 1:50 AM
finance.yahoo.com logoOtonomy, Inc. (OTIC) Stock Historical Prices & Data - Yahoo Finance
finance.yahoo.com - January 23 at 1:11 AM
finanznachrichten.de logoOtonomy, Inc.: Otonomy Provides Corporate Update
finanznachrichten.de - December 21 at 12:04 AM
finance.yahoo.com logoOtonomy Provides Corporate Update
finance.yahoo.com - December 19 at 6:40 PM
marketbeat.com logo
marketbeat.com - December 19 at 4:46 PM
investorplace.com logo5 Investors Betting Big on Otonomy (OTIC) Stock
investorplace.com - November 30 at 1:17 PM
investorplace.com logoWhy Is Otonomy (OTIC) Stock Up 97% Today?
investorplace.com - November 29 at 1:04 PM
finance.yahoo.com logoOtonomy Reports Third Quarter 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - November 10 at 6:24 PM
reuters.com logoOTIC.OQ - Otonomy Inc | Stock Price & Latest News | Reuters
reuters.com - November 6 at 9:21 AM
marketscreener.com logoOTONOMY, INC. : Results of Operations and Financial Condition (form 8-K) - Marketscreener.com
marketscreener.com - October 14 at 9:09 AM
investing.com logoU.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.83% By Investing.com - Investing.com
investing.com - October 13 at 11:08 PM
finance.yahoo.com logoLianBio To Shut BridgeBio-Partnered Bile Duct Cancer Drug Trial - Yahoo Finance
finance.yahoo.com - October 13 at 11:08 PM
streetinsider.com logoU.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.83% - StreetInsider.com
streetinsider.com - October 13 at 6:07 PM
benzinga.com logoOtonomy shares are trading lower after the company reported higher dose cohorts for OTO-413 demonstrated no clinically meaningful improvement for patients from baseline. - Otonomy (NASDAQ:OTIC) - Benzinga
benzinga.com - October 13 at 6:07 PM
marketscreener.com logoOtonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss -- Shares Nosedive - Marketscreener.com
marketscreener.com - October 13 at 6:07 PM
benzinga.com logoWhy Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday’s Mid- - Benzinga
benzinga.com - October 13 at 1:07 PM
marketscreener.com logoOtonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss - Marketscreener.com
marketscreener.com - October 13 at 1:07 PM
globenewswire.com logoOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss - GlobeNewswire
globenewswire.com - October 13 at 1:07 PM
finance.yahoo.com logoOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss - Yahoo Finance
finance.yahoo.com - October 13 at 8:07 AM
finance.yahoo.com logoOtonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss
finance.yahoo.com - October 13 at 8:06 AM
reuters.com logoOTIC.O - Otonomy Inc | Stock Price & Latest News | Reuters
reuters.com - October 7 at 2:37 PM
marketscreener.com logoAPPLIED GENETIC TECHNOLOGIES CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.com
marketscreener.com - September 27 at 9:36 PM
marketscreener.com logoOTONOMY, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Marketscreener.com
marketscreener.com - September 17 at 2:39 AM
streetinsider.com logoForm SC 13G/A OTONOMY, INC. Filed by: FEDERATED HERMES, INC. - StreetInsider.com
streetinsider.com - September 9 at 6:07 PM
finance.yahoo.com logoAGTC to Participate in Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - September 1 at 11:20 PM
marketscreener.com logoOtonomy : Costs Associated with Exit or Disposal Activities - Form 8-K - Marketscreener.com
marketscreener.com - August 11 at 3:51 AM
marketscreener.com logoOTONOMY, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers (form 8-K) - Marketscreener.com
marketscreener.com - August 9 at 6:42 PM
benzinga.com logoShort Volatility Alert: Otonomy, Inc. - Benzinga
benzinga.com - August 6 at 5:18 AM
benzinga.com logoThis Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket
benzinga.com - August 3 at 8:34 AM
seekingalpha.com logoOTIC stock downgraded at H.C. Wainwright as tinnitus candidate fails (NASDAQ:OTIC) - Seeking Alpha
seekingalpha.com - August 2 at 7:36 PM
marketscreener.com logoHC Wainwright Downgrades Otonomy to Neutral From Buy - Marketscreener.com
marketscreener.com - August 2 at 9:35 AM
uk.investing.com logoDaily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial By Benzinga - Investing.com UK
uk.investing.com - August 2 at 9:35 AM
marketwatch.com logoOtonomy Shares Plumb New Depths on Failure of Lead Program >OTIC - MarketWatch
marketwatch.com - August 2 at 12:47 AM
gurufocus.com logoAGTC to Participate in Upcomin - GuruFocus.com
gurufocus.com - August 1 at 7:35 PM
marketscreener.com logoPiper Sandler Adjusts Otonomy Price Target to $3 From $6, Maintains Overweight Rating - Marketscreener.com
marketscreener.com - August 1 at 2:32 PM
seekingalpha.com logoVirax, Aethlon top healthcare gainers; while Otonomy, Kazia lead losers' pack - Seeking Alpha
seekingalpha.com - August 1 at 2:32 PM
finance.yahoo.com logoOtonomy Shares Sink After Stopping Mid-Stage Tinnitus Study
finance.yahoo.com - August 1 at 2:32 PM
benzinga.com logoOtonomy Reports Results From Phase 2 Clinical Trial Of OTO-313 In Patients With Tinnitus; Co. Reports 'OT - Benzinga
benzinga.com - August 1 at 8:14 AM
globenewswire.com logoOtonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus - GlobeNewswire
globenewswire.com - August 1 at 8:14 AM
finance.yahoo.com logoOtonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus
finance.yahoo.com - August 1 at 8:14 AM
marketbeat.com logo
marketbeat.com - August 1 at 7:25 AM
MarketBeat logoOtonomy (NASDAQ:OTIC) Research Coverage Started at StockNews.com
americanbankingnews.com - July 30 at 2:08 AM
nasdaq.com logoWalmart Cuts Q2, FY Profit Outlook; Stock Down - Nasdaq
nasdaq.com - July 27 at 3:56 PM
finance.yahoo.com logoTwo Clinical Studies to Treat Mild-to-Moderate COVID-19 at Home Reveal Value of Exscalate, Dompé's AI Platform for Drug Design - Yahoo Finance
finance.yahoo.com - July 27 at 3:56 PM
benzinga.com logoOtonomy shares are trading lower after the company reported Q2 earnings results. - Benzinga - Benzinga
benzinga.com - July 26 at 2:50 PM
marketscreener.com logoAGTC Receives Positive Type C Meeting Feedback from the FDA for the Company's Design and Operating Procedures of its Planned cGMP Manufacturing Facility - Marketscreener.com
marketscreener.com - July 26 at 9:47 AM
rttnews.com logoHealthStream EPS Tops Estimate, MEDP Revises Forecast, OTIC To Report Tinnitus Trial Data In August - RTTNews
rttnews.com - July 26 at 9:47 AM
Get Otonomy News Delivered to You Automatically

Sign up to receive the latest news and ratings for OTIC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:OTIC) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -